The store will not work correctly when cookies are disabled.
3-Hydroxy-1-methyl-5-((3-(trifluoromethyl)phenoxy)methyl)-1H-pyrazole-4-carboxylic acid
ID: ALA4458056
PubChem CID: 85469100
Max Phase: Preclinical
Molecular Formula: C13H11F3N2O4
Molecular Weight: 316.24
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1nc(O)c(C(=O)O)c1COc1cccc(C(F)(F)F)c1
Standard InChI: InChI=1S/C13H11F3N2O4/c1-18-9(10(12(20)21)11(19)17-18)6-22-8-4-2-3-7(5-8)13(14,15)16/h2-5H,6H2,1H3,(H,17,19)(H,20,21)
Standard InChI Key: ZOSMQYUVHWSYCZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
3.8226 -17.8218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4856 -17.3439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2312 -16.5631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4140 -16.5631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1597 -17.3439 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9374 -16.1518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9343 -15.3346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8226 -18.6390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9339 -15.9018 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6466 -16.5577 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1879 -17.7512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1863 -18.5684 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8933 -18.9825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8893 -19.7994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5954 -20.2051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3049 -19.8020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3039 -18.9764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5972 -18.5702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0109 -18.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7193 -18.9742 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.0096 -17.7495 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.7126 -18.1516 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4 5 2 0
2 3 2 0
1 2 1 0
3 4 1 0
5 1 1 0
3 6 1 0
6 7 2 0
1 8 1 0
4 9 1 0
6 10 1 0
2 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
17 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 316.24 | Molecular Weight (Monoisotopic): 316.0671 | AlogP: 2.42 | #Rotatable Bonds: 4 |
Polar Surface Area: 84.58 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.05 | CX Basic pKa: ┄ | CX LogP: 3.36 | CX LogD: -1.52 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.90 | Np Likeness Score: -1.14 |
References
1. Pippione AC, Sainas S, Goyal P, Fritzson I, Cassiano GC, Giraudo A, Giorgis M, Tavella TA, Bagnati R, Rolando B, Caing-Carlsson R, Costa FTM, Andrade CH, Al-Karadaghi S, Boschi D, Friemann R, Lolli ML.. (2019) Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies., 163 [PMID:30529545] [10.1016/j.ejmech.2018.11.044] |